Cardiovascular safety of mirabegron add ‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study

ConclusionsCardiovascular ‐related adverse events were uncommon in both treatment groups. Mirabegron is a well‐tolerated add‐on therapy to tamsulosin in Japanese and Korean males with residual overactive bladder symptoms.

Source: LUTS: Lower Urinary Tract Symptoms - January 3, 2021 Category: Urology & Nephrology Authors: Takao Katoh, Hidehiro Kakizaki, Kyu ‐Sung Lee, Kota Ishida, Daisuke Katou, Osamu Yamamoto, Jar Jar Jong, Budiwan Sumarsono, Satoshi Uno, Osamu Yamaguchi Tags: ORIGINAL ARTICLE Source Type: research